• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清基质金属蛋白酶与左心房重构——霍恩研究。

Serum Matrix Metalloproteinases and Left Atrial Remodeling-The Hoorn Study.

机构信息

Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands.

Department of Internal Medicine, Maastricht University Medical Centre, 6202 AZ Maastricht, The Netherlands.

出版信息

Int J Mol Sci. 2020 Jul 13;21(14):4944. doi: 10.3390/ijms21144944.

DOI:10.3390/ijms21144944
PMID:32668720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7404388/
Abstract

Extracellular matrix protein turnover may play an important role in left atrial (LA) remodelling. The aim is to investigate the associations between matrix metalloproteinase (MMPs), tissue inhibitor of metalloproteinase (TIMP-1) and LA volume index (LAVI) and if these associations are independent of TIMP-1 levels. Participants from The Hoorn Study, a population-based cohort study ( = 674), underwent echocardiography. Serum MMPs (i.e., MMP-1, MMP-2, MMP-3, MMP-9, and MMP-10) and TIMP-1 levels were measured with ELISA. Multiple linear regression analyses were used. MMP-1 levels were not associated with LAVI. Higher MMP-2 levels were associated with larger LAVI (regression coefficient per SD increase in MMP (95% CI); 0.03 (0.01; 0.05). Higher MMP-3 and MMP-9 levels were associated with smaller LAVI; -0.04 (-0.07; -0.01) and -0.04 (-0.06; -0.02) respectively. Only in women were higher MMP-10 levels associated with larger LAVI; 0.04 (0.00; 0.07, -interaction 0.04). Additionally, only in women were higher TIMP-1 levels associated with smaller LAVI; -0.05 (-0.09; -0.01, -interaction 0.03). The associations between MMPs and LAVI were independent of TIMP-1 levels. In conclusion, serum MMPs are associated with LAVI, independent of CVD risk factors and TIMP-1 levels. In addition, these associations differ according to sex and within MMP subgroups. This shows that the role of MMPs in LA remodelling is complex.

摘要

细胞外基质蛋白的周转率可能在左心房(LA)重构中发挥重要作用。本研究旨在探讨基质金属蛋白酶(MMPs)、金属蛋白酶组织抑制剂(TIMP-1)与左心房容积指数(LAVI)之间的相关性,以及这些相关性是否独立于 TIMP-1 水平。来自 Hoorn 研究的参与者为一个基于人群的队列研究(=674),接受了超声心动图检查。使用 ELISA 法测量血清 MMPs(即 MMP-1、MMP-2、MMP-3、MMP-9 和 MMP-10)和 TIMP-1 水平。使用多元线性回归分析。MMP-1 水平与 LAVI 无关。较高的 MMP-2 水平与较大的 LAVI 相关(MMP 每标准差增加的回归系数(95%置信区间);0.03(0.01;0.05)。较高的 MMP-3 和 MMP-9 水平与较小的 LAVI 相关;-0.04(-0.07;-0.01)和-0.04(-0.06;-0.02)。只有在女性中,较高的 MMP-10 水平与较大的 LAVI 相关;0.04(0.00;0.07,-交互作用 0.04)。此外,只有在女性中,较高的 TIMP-1 水平与较小的 LAVI 相关;-0.05(-0.09;-0.01,-交互作用 0.03)。MMP 与 LAVI 之间的相关性独立于 TIMP-1 水平。总之,血清 MMPs 与 LAVI 相关,独立于 CVD 危险因素和 TIMP-1 水平。此外,这些相关性根据性别和 MMP 亚组而有所不同。这表明 MMPs 在 LA 重构中的作用是复杂的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9f/7404388/1b6ec6912856/ijms-21-04944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9f/7404388/1b6ec6912856/ijms-21-04944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad9f/7404388/1b6ec6912856/ijms-21-04944-g001.jpg

相似文献

1
Serum Matrix Metalloproteinases and Left Atrial Remodeling-The Hoorn Study.血清基质金属蛋白酶与左心房重构——霍恩研究。
Int J Mol Sci. 2020 Jul 13;21(14):4944. doi: 10.3390/ijms21144944.
2
Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis.风湿性二尖瓣狭窄患者循环纤维化生物标志物与左心房功能和左心房容积指数的相关性。
Narra J. 2024 Apr;4(1):e293. doi: 10.52225/narra.v4i1.293. Epub 2024 Jan 8.
3
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.基质金属蛋白酶-2、-3、-10及金属蛋白酶组织抑制剂-1的血浆水平与1型糖尿病患者的血管并发症相关:欧洲糖尿病前瞻性并发症研究
Cardiovasc Diabetol. 2015 Mar 10;14:31. doi: 10.1186/s12933-015-0195-2.
4
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.基质金属蛋白酶/金属蛋白酶组织抑制剂:基质成分蛋白水解决定因素的变化与高血压性心脏病的结构、功能及临床表现之间的关系
Circulation. 2006 May 2;113(17):2089-96. doi: 10.1161/CIRCULATIONAHA.105.573865. Epub 2006 Apr 24.
5
Matrix metalloproteinases and their inhibitors in acute viral hepatitis.急性病毒性肝炎中的基质金属蛋白酶及其抑制剂
J Viral Hepat. 2002 May;9(3):189-93. doi: 10.1046/j.1365-2893.2002.00351.x.
6
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌金属蛋白酶及其组织抑制剂在肌萎缩侧索硬化症患者血清和脑脊液中的变化。
Eur J Neurol. 2010 Feb;17(2):226-31. doi: 10.1111/j.1468-1331.2009.02775.x. Epub 2009 Oct 1.
7
Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).年龄对血浆基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)的影响。
J Card Fail. 2007 Sep;13(7):530-40. doi: 10.1016/j.cardfail.2007.04.010.
8
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.掌腱膜挛缩症患者血清和组织中的基质金属蛋白酶及金属蛋白酶组织抑制剂
Plast Reconstr Surg. 2003 Oct;112(5):1279-86. doi: 10.1097/01.PRS.0000081462.40448.49.
9
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?心房颤动中的血栓形成与基质金属蛋白酶-1及其抑制剂金属蛋白酶组织抑制因子-1有关吗?
Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27.
10
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.痴呆患者血浆中基质金属蛋白酶及其抑制剂的概况
Int Psychogeriatr. 2008 Feb;20(1):67-76. doi: 10.1017/S1041610207005790. Epub 2007 Aug 15.

引用本文的文献

1
The association between stress hyperglycemia and poor outcome in critically ill children is modulated by hyperlactatemia.危重症儿童应激性高血糖与不良预后之间的关联受高乳酸血症调节。
Front Endocrinol (Lausanne). 2025 Jun 18;16:1518746. doi: 10.3389/fendo.2025.1518746. eCollection 2025.
2
Identification of Circulating Plasma Proteins as a Mediator of Hypertension-Driven Cardiac Remodeling: A Mediation Mendelian Randomization Study.鉴定循环血浆蛋白作为高血压驱动的心脏重构的中介物:一项中介孟德尔随机化研究。
Hypertension. 2024 May;81(5):1132-1144. doi: 10.1161/HYPERTENSIONAHA.123.22504. Epub 2024 Mar 15.
3
Long Non-coding RNA Involved in the Pathophysiology of Atrial Fibrillation.

本文引用的文献

1
Profiling of the plasma proteome across different stages of human heart failure.跨人心力衰竭不同阶段的血浆蛋白质组学分析。
Nat Commun. 2019 Dec 20;10(1):5830. doi: 10.1038/s41467-019-13306-y.
2
Cohort Profile: The Hoorn Studies.队列简介:霍恩研究
Int J Epidemiol. 2018 Apr 1;47(2):396-396j. doi: 10.1093/ije/dyx227.
3
Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.循环基质金属蛋白酶与 1 型糖尿病患者的动脉僵硬度相关:三项队列研究的汇总分析。
参与心房颤动病理生理学的长链非编码RNA
Cardiovasc Drugs Ther. 2025 Apr;39(2):435-458. doi: 10.1007/s10557-023-07491-8. Epub 2023 Sep 13.
4
Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity-Pathogenesis and Involvement of the Extracellular Matrix.肥胖症进程中心肌重构和纤维化:细胞外基质的发病机制和作用。
Int J Mol Sci. 2022 Apr 11;23(8):4195. doi: 10.3390/ijms23084195.
5
Levels of Serum sST2, MMP-3, and Gal-3 in Patients with Essential Hypertension and Their Correlation with Left Ventricular Hypertrophy.原发性高血压患者血清sST2、MMP-3和Gal-3水平及其与左心室肥厚的相关性
Evid Based Complement Alternat Med. 2021 Oct 12;2021:7262776. doi: 10.1155/2021/7262776. eCollection 2021.
6
Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies.男女阵发性心房颤动患者循环生物标志物的差异:来自 AF-RISK 和 RACE V 研究的结果。
Europace. 2022 Feb 2;24(2):193-201. doi: 10.1093/europace/euab179.
7
[Change of serum levels of pentraxin-3 and syndecan-4 in children with chronic heart failure].[慢性心力衰竭患儿血清中五聚体蛋白-3和多功能蛋白聚糖-4水平的变化]
Zhongguo Dang Dai Er Ke Za Zhi. 2021 May;23(5):513-518. doi: 10.7499/j.issn.1008-8830.2101108.
Cardiovasc Diabetol. 2017 Oct 25;16(1):139. doi: 10.1186/s12933-017-0620-9.
4
Towards integrating extracellular matrix and immunological pathways.迈向整合细胞外基质与免疫途径。
Cytokine. 2017 Oct;98:79-86. doi: 10.1016/j.cyto.2017.03.004. Epub 2017 Mar 18.
5
Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism.原发性醛固酮增多症中心脏功能障碍与炎症标志物升高相关
Endocrinol Metab (Seoul). 2016 Dec;31(4):567-576. doi: 10.3803/EnM.2016.31.4.567. Epub 2016 Nov 3.
6
Changes in activities of circulating MMP-2 and MMP-9 in patients suffering from heart failure in relation to gender, hypertension and treatment: a cross-sectional study.心力衰竭患者循环中基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)活性与性别、高血压及治疗的关系:一项横断面研究
Physiol Res. 2016 Sep 19;65 Suppl 1:S149-52. doi: 10.33549/physiolres.933412.
7
Distinct biological events generated by ECM proteolysis by two homologous collagenases.由两种同源胶原酶对细胞外基质进行蛋白水解所产生的不同生物学事件。
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10884-9. doi: 10.1073/pnas.1519676113. Epub 2016 Sep 14.
8
Aldosterone Induces Tissue Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen Accumulation: From Clinical to Bench Studies.醛固酮诱导金属蛋白酶组织抑制剂-1表达并进一步促进胶原蛋白积累:从临床研究到基础研究
Hypertension. 2016 Jun;67(6):1309-20. doi: 10.1161/HYPERTENSIONAHA.115.06768. Epub 2016 Apr 25.
9
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.反映射血分数保留的心力衰竭中促纤维化过程的血浆生物标志物:来自ARNI与ARB对射血分数保留的心力衰竭管理的前瞻性比较研究的数据。
Circ Heart Fail. 2016 Jan;9(1). doi: 10.1161/CIRCHEARTFAILURE.115.002551.
10
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.循环中的基质金属蛋白酶-1组织抑制剂与醛固酮诱导的舒张功能障碍有关。
J Hypertens. 2015 Sep;33(9):1922-30; discussion 1930. doi: 10.1097/HJH.0000000000000619.